Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(1379/week)
    • Manufacturing(708/week)
    • Energy(572/week)
    • Technology(1289/week)
    • Other Manufacturing(492/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

MRI contrast agent

Mar 23, 2020
2020 Contrast Media Market Assessment Report - Bayer and Daiichi Sankyo are the Leading Players
Dec 03, 2019
Artificial intelligence software confirms the results of a large scale comparison of ProHance® (Gadoteridol) Injection, 279.3 mg/mL and Gadavist® (gadobutrol) Injection in MRI of the brain (the TRUTH study)
Nov 28, 2019
Global Contrast Agents Market Forecast, 2019-2025 - Adverse Reimbursement Scenario & High Cost of Imaging Modalities in Emerging Countries May Hamper Growth
Aug 20, 2019
RSNA: Some Pregnant Women Are Exposed to Gadolinium in Early Pregnancy
Feb 04, 2019
Global Imaging Agents Market Report 2019: Annual Estimates & Forecasts 2016-2024 - Technology Dynamics, Innovations/Approvals, Recent Industry Activity & Focus on Key Players
Nov 26, 2018
Guerbet To Showcase Innovative Diagnostic and Interventional Imaging Solutions at RSNA 2018
Nov 26, 2018
Artificial Intelligence May Help Reduce Gadolinium Dose in MRI
Oct 24, 2018
IQ-AI Files Patent for Contrast-Free Imaging
Oct 19, 2018
WMIC 2018 Young Investigator of the Year Awarded to Caltech's Dr. George J. Lu for Research in Combining MRI and Ultrasound Technologies
Oct 15, 2018
Global $6.87 Billion Contrast Agents/Media Market to 2025
May 07, 2018
Contrast Media Agents Market Size Worth $5.96 Billion By 2025: Grand View Research, Inc.
Dec 27, 2017
Gadolinium-based contrast agents: update from Guerbet LLC on U.S. Food and Drug Administration (FDA) requirements
Sep 08, 2017
Guerbet Statement Following FDA Medical Imaging Drugs Advisory Committee September 8, 2017
Sep 05, 2017
FDA Approves Guerbet's Dotarem® (gadoterate meglumine) for Pediatric Patients Younger Than Two Years

Latest News

Aug 5, 2025

Eku Energy’s battery storage projects in Essex and Buckinghamshire are commissioned with BESS supplier NHOA...

Aug 5, 2025

Mission Success for Rocket Lab’s Latest Constellation Deployment Launch for iQPS

Aug 5, 2025

American Water Announces Pricing of Common Stock Offering of 7,042,254 Shares with a Forward Component

Aug 5, 2025

Toshiba Releases Lens-Reduction Type CCD Linear Image Sensor with Low Random Noise That Helps Improve Image...

Aug 5, 2025

Jeh Aerospace Secures $11 Million from Elevation Capital, General Catalyst to Scale Next-Generation Aerospace...

Aug 5, 2025

Venture Global Calcasieu Pass Receives Uprate Approval from U.S. Department of Energy

Aug 5, 2025

Otter Tail Corporation Announces Second Quarter Earnings and Increases Annual Earnings Guidance

Aug 5, 2025

Geospace Technologies Acquires National Lab Developed Heartbeat Detector Technology

View all News

Agenda

30
September
PortugalTroia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia